Table 2.
Responses of patients to the study questionnaire
| Responses | Patients with IPF N=115 |
| Having a control visit during the pandemic period*, n (%) | |
| Present | 85 (73.9) |
| Absent | 30 (26.1) |
| Having a scheduled blood analysis during the pandemic period*, n (%) | |
| Present | 60 (52.2) |
| Absent | 55 (47.8) |
| Blood analysis during the pandemic period*, n (%) | |
| Having no scheduled blood testing | 55 (47.8) |
| Having a scheduled blood testing but not going for testing | 32 (27.8) |
| Having had the blood testing in a healthcare centre | 18 (15.7) |
| Not having had the blood testing after discussing with the treating physician | 10 (8.7) |
| Doctor appointment during the pandemic period*, n (%) | |
| Having no doctor appointment | 5 (4.3) |
| Having doctor appointment but not attending due to COVID-19 fear | 60 (52.2) |
| Postponed after discussing with treating physician | 33 (28.7) |
| Having attended the appointment | 17 (14.8) |
| Having contacted the treating physician during the pandemic period*, n (%) | |
| Present | 41 (35.7) |
| Absent | 74 (64.3) |
| Route of communication, n (%) | |
| Not having contacted | 74 (64.3) |
| Phone | 40 (34.8) |
| Social media | 1 (0.9) |
| Drug continuation during the pandemic period*, n (%) | |
| Present | 89 (77.4) |
| Absent | 26 (22.6) |
| Worsened complaints during the pandemic period*, n (%) | |
| Having no complaints | 52 (45.2) |
| Having reached the treating physician | 17 (14.8) |
| Unable to reach the treating physician and therefore visiting a healthcare centre | 9 (7.8) |
| Not having visited a healthcare centre due to fear and thus having waited | 37 (32.2) |
| Side effects related to antifibrotic drugs, n (%) | |
| Present | 30 (26.1) |
| Absent | 85 (73.9) |
| Having diagnosed with COVID-19, n (%) | |
| Present | 2 (1.7) |
| Absent | 113 (98.3) |
| Anxiety status, n (%) | |
| Abnormal+borderline | 44 (38.3) |
| Normal | 71 (61.7) |
| Depression status, n (%) | |
| Abnormal+borderline | 31 (27.0) |
| Normal | 84 (73.0) |
*In the present study, the pandemic period includes the period between March 2020 and May 2020, which corresponds to the first 3 months after the official announcement of the COVID-19 pandemic in Turkey.
IPF, idiopathic pulmonary fibrosis.